DOCS / Doximity, Inc. - Pengajuan SECLaporan Tahunan, Pernyataan Proksi

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): August 28, 2025 Doximity, Inc. (E

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): August 28, 2025 Doximity, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-40508 27-2485512 (State or Other Jurisdiction of Incorporation) (Commission File Num

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 13, 2025 Doximity, Inc. (E

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 13, 2025 Doximity, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-40508 27-2485512 (State or Other Jurisdiction of Incorporation) (Commission File Num

Nate Gross Advisor Agreement

Exhibit 10.1 CONSULTING AGREEMENT This Consulting Agreement (this “Agreement”) is made and entered into as of June 17, 2025 the “Effective Date”) by and between Doximity, Inc., a Delaware corporation with its principal place of business at 500 Third Street, Suite 510, San Francisco, CA 94107 (the “Company”), and Nate Gross, (“Consultant”) (each herein referred to individually as a “Party,” or coll

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001

Doximity Announces Fiscal 2026 First Quarter Financial Results Total revenues of $145.9 million, up 15% year-over-year Operating cash flow of $62.1 million, up 51% year-over-year Free cash flow of $60.1 million, up 52% year-over-year

Exhibit 99.1 Doximity Announces Fiscal 2026 First Quarter Financial Results Total revenues of $145.9 million, up 15% year-over-year Operating cash flow of $62.1 million, up 51% year-over-year Free cash flow of $60.1 million, up 52% year-over-year SAN FRANCISCO, Calif., August 7, 2025 - Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced results

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 7, 2025 Doximity, Inc. (Ex

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 7, 2025 Doximity, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-40508 27-2485512 (State or Other Jurisdiction of Incorporation) (Commission File Numb

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy State

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Definitive Proxy State

Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 10, 2025 Doximity, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-40508 27-2485512 (State or Other Jurisdiction of Incorporation) (Commission File Numbe

1

Thank you, Nate! After 15 wonderful years, our co-founder, partner, and pyramid topper (!), Dr.

Subsidiaries of the Registrant.

Exhibit 21.1 SUBSIDIARIES OF DOXIMITY Name of Subsidiary Jurisdiction of Incorporation or Organization Curative Talent, LLC Delaware, U.S. Amion, LLC Delaware, U.S.

As filed with the U.S. Securities and Exchange Commission on May 20, 2025

As filed with the U.S. Securities and Exchange Commission on May 20, 2025 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Doximity, Inc. (Exact name of registrant as specified in its charter) Delaware 27-2485512 (State or other jurisdiction of incorporation or organization) (I.R.S. Employ

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended March 31, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-40508

Filing Fee Table.

Exhibit 107 Calculation of Filing Fee Tables Form S-8 (Form Type) Doximity, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered(1) Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Equity Class A common stock, $0.001 par

Doximity Announces Fourth Quarter and Fiscal Year 2025 Financial Results Q4 total revenues of $138.3 million, up 17% year-over-year Q4 operating cash flow of $98.5 million, up 54% year-over-year Q4 free cash flow of $97.0 million, up 56% year-over-ye

Exhibit 99.1 Doximity Announces Fourth Quarter and Fiscal Year 2025 Financial Results Q4 total revenues of $138.3 million, up 17% year-over-year Q4 operating cash flow of $98.5 million, up 54% year-over-year Q4 free cash flow of $97.0 million, up 56% year-over-year Fiscal year 2025 total revenues of $570.4 million, up 20% year-over-year Fiscal year 2025 operating cash flow of $273.3 million, up 48

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 15, 2025 Doximity, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-40508 27-2485512 (State or Other Jurisdiction of Incorporation) (Commission File Number

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number

Doximity Announces Fiscal 2025 Third Quarter Financial Results Total revenues of $168.6 million, up 25% year-over-year Net income growth of 57% and adjusted EBITDA growth of 39% year-over-year

Exhibit 99.1 Doximity Announces Fiscal 2025 Third Quarter Financial Results Total revenues of $168.6 million, up 25% year-over-year Net income growth of 57% and adjusted EBITDA growth of 39% year-over-year SAN FRANCISCO, Calif., February 6, 2025 - Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2025 third quarter ended

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 6, 2025 Doximity, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-40508 27-2485512 (State or Other Jurisdiction of Incorporation) (Commission File Nu

DOCS / Doximity, Inc. / Durable Capital Partners LP - AMENDMENT TO SC 13G Passive Investment

SC 13G/A 1 doximity-sc13ga093024.htm AMENDMENT TO SC 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* Doximity, Inc. (Name of Issuer) Class A common stock, $0.001 par value per share (Title of Class of Securities) 26622P107 (CUSIP Number) September 30, 2024 (Date of Event Which Requires Filing of t

DOCS / Doximity, Inc. / WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC - SC 13G Passive Investment

SC 13G 1 tm2428293d20sc13g.htm SC 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G* (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2 (Amendment No. )* Doximity, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 26622P107 (CUSIP Number) S

DOCS / Doximity, Inc. / EMERGENCE CAPITAL PARTNERS II LP - SC 13G/A Passive Investment

SC 13G/A 1 d874958dsc13ga.htm SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 3)* Doximity, Inc. (Name of Issuer) CLASS A COMMON STOCK, $0.001 PAR VALUE PER SHARE (Title of Class of Securities) 26622P107 (CUSIP Number) September 30, 2024 (Date of Event Which Requires Filing of this Statement) Che

Doximity Announces Fiscal 2025 Second Quarter Financial Results Total revenues of $136.8 million, up 20% year-over-year Net income growth of 44% and adjusted EBITDA growth of 41% year-over-year

Exhibit 99.1 Doximity Announces Fiscal 2025 Second Quarter Financial Results Total revenues of $136.8 million, up 20% year-over-year Net income growth of 44% and adjusted EBITDA growth of 41% year-over-year SAN FRANCISCO, Calif., November 7, 2024 - Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2025 second quarter end

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file numbe

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 7, 2024 Doximity, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-40508 27-2485512 (State or Other Jurisdiction of Incorporation) (Commission File Nu

Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): August 29, 2024 Doximity, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-40508 27-2485512 (State or Other Jurisdiction of Incorporation) (Commission File Num

Non-Employee Director Compensation Policy.

Exhibit 10.6 DOXIMITY, INC. NON-EMPLOYEE DIRECTOR COMPENSATION POLICY The purpose of this Non-Employee Director Compensation Policy (the “Policy”) of Doximity, Inc., a Delaware corporation (the “Company”), is to provide a total compensation package that enables the Company to attract and retain, on a long-term basis, high-caliber directors who are not employees or officers of the Company or its su

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 8, 2024 Doximity, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-40508 27-2485512 (State or Other Jurisdiction of Incorporation) (Commission File Numb

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001

Doximity Announces Fiscal 2025 First Quarter Financial Results Total revenues of $126.7 million, up 17% year-over-year Net income growth of 46% and adjusted EBITDA growth of 42% year-over-year

Exhibit 99.1 Doximity Announces Fiscal 2025 First Quarter Financial Results Total revenues of $126.7 million, up 17% year-over-year Net income growth of 46% and adjusted EBITDA growth of 42% year-over-year SAN FRANCISCO, Calif., August 8, 2024 - Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2025 first quarter ended J

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Definitive Proxy State

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy State

DOCS / Doximity, Inc. / Durable Capital Partners LP - SCHEDULE FILED TO REPORT ACQUISITION OF BENEFICIAL OWNERSHIP Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Doximity, Inc. (Name of Issuer) Class A common stock, $0.001 par value per share (Title of Class of Securities) 26622P107 (CUSIP Number) June 25, 2024 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule

Subsidiaries of the Registrant.

Exhibit 21.1 SUBSIDIARIES OF DOXIMITY Name of Subsidiary Jurisdiction of Incorporation or Organization Curative Talent, LLC Delaware, U.S. Amion, LLC Delaware, U.S.

Doximity Inc.

Exhibit 97.1 DOXIMITY, INC. COMPENSATION RECOVERY POLICY Adopted as of October 26, 2023 Doximity, Inc., a Delaware corporation (the “Company”), has adopted a Compensation Recovery Policy (this “Policy”) as described below. 1.Overview The Policy sets forth the circumstances and procedures under which the Company shall recover Erroneously Awarded Compensation from Covered Persons (as defined below)

Filing Fee Table.

Exhibit 107 Calculation of Filing Fee Tables Form S-8 (Form Type) Doximity, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered(1) Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Equity Class A common stock, $0.001 par

As filed with the U.S. Securities and Exchange Commission on May 23, 2024

As filed with the U.S. Securities and Exchange Commission on May 23, 2024 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 POST EFFECTIVE AMENDMENT NO. 1 to FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Doximity, Inc. (Exact name of registrant as specified in its charter) Delaware 27-2485512 (State or other jurisdiction of incorporati

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended March 31, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-40508

As filed with the U.S. Securities and Exchange Commission on May 23, 2024

As filed with the U.S. Securities and Exchange Commission on May 23, 2024 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Doximity, Inc. (Exact name of registrant as specified in its charter) Delaware 27-2485512 (State or other jurisdiction of incorporation or organization) (I.R.S. Employ

Doximity Announces Fourth Quarter and Fiscal Year 2024 Financial Results Fiscal year 2024 total revenues of $475.4 million, up 13% year-over-year Fiscal year 2024 net income growth of 31% and adjusted EBITDA growth of 25% year-over-year Q4 total reve

Exhibit 99.1 Doximity Announces Fourth Quarter and Fiscal Year 2024 Financial Results Fiscal year 2024 total revenues of $475.4 million, up 13% year-over-year Fiscal year 2024 net income growth of 31% and adjusted EBITDA growth of 25% year-over-year Q4 total revenues of $118.1 million, up 6% year-over-year Q4 net income growth of 32% and adjusted EBITDA growth of 15% year-over-year SAN FRANCISCO,

Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 16, 2024 Doximity, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-40508 27-2485512 (State or Other Jurisdiction of Incorporation) (Commission File Number

Marketing Solutions: Revenue Recognition and Billing FAQ LEGAL DISCLAIMER 2 This presentation and associated commentary may contain forward-looking statements, including statements regarding expectations of future results of operations or financial p

Marketing Solutions: Revenue Recognition and Billing FAQ LEGAL DISCLAIMER 2 This presentation and associated commentary may contain forward-looking statements, including statements regarding expectations of future results of operations or financial performance of Doximity, the calculation of certain of our key financial and operating metrics, and the assumptions underlying those statements.

DOCS / Doximity, Inc. / EMERGENCE CAPITAL PARTNERS II LP - SC 13G/A Passive Investment

SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 2)* Doximity, Inc. (Name of Issuer) CLASS A COMMON STOCK, $0.001 PAR VALUE PER SHARE (Title of Class of Securities) 26622P107 (CUSIP Number) December 31, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to desig

DOCS / Doximity, Inc. / Tangney Jeffrey - SC 13G/A Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES AND EXCHANGE ACT OF 1934 (Amendment No. 2)* Doximity, Inc. (Name of Issuer) Class A common stock (Title of Class of Securities) 26622P 107 (CUSIP Number) December 31, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which

DOCS / Doximity, Inc. / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 2)* Name of issuer: Doximity, Inc. Class A Title of Class of Securities: Common Stock CUSIP Number: 26622P107 Date of Event Which Requires Filing of this Statement: December 29, 2023 Check the appropriate box to designate the rule pursuant to which this Schedule is filed

DOCS / Doximity, Inc. / Clearbridge Investments, LLC Passive Investment

SC 13G/A 1 doxim23a1.htm CUSIP NO. 26622P107 13G Page 1 of 7 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* Doximity, Inc. (Name of Issuer) Class A common stock, $0.001 par value per share (Title of Class of Securities) 26622P107 (CUSIP Number) December 31, 2023 (Date of Event Which Requires Filing o

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 8, 2024 Doximity, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-40508 27-2485512 (State or Other Jurisdiction of Incorporation) (Commission File Nu

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number

Doximity Announces Fiscal 2024 Third Quarter Financial Results Total revenues of $135.3 million, up 17% year-over-year Net income margin of 35% and adjusted EBITDA margin of 54% Net income growth of 43% and adjusted EBITDA growth of 32% year-over-yea

Exhibit 99.1 Doximity Announces Fiscal 2024 Third Quarter Financial Results Total revenues of $135.3 million, up 17% year-over-year Net income margin of 35% and adjusted EBITDA margin of 54% Net income growth of 43% and adjusted EBITDA growth of 32% year-over-year SAN FRANCISCO, Calif., February 8, 2024 - Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, tod

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 9, 2023 Doximity, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-40508 27-2485512 (State or Other Jurisdiction of Incorporation) (Commission File Nu

Doximity Announces Fiscal 2024 Second Quarter Financial Results Total revenues of $113.6 million, up 11% year-over-year Net income margin of 27% and adjusted EBITDA margin of 48% Net income growth of 16% and adjusted EBITDA growth of 18% year-over-ye

Exhibit 99.1 Doximity Announces Fiscal 2024 Second Quarter Financial Results Total revenues of $113.6 million, up 11% year-over-year Net income margin of 27% and adjusted EBITDA margin of 48% Net income growth of 16% and adjusted EBITDA growth of 18% year-over-year SAN FRANCISCO, Calif., November 9, 2023 - Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, to

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file numbe

Doximity Announces Fiscal 2024 First Quarter Financial Results Total revenues of $108.5 million, up 20% year-over-year Operating cash flow of $57.2 million, up 28% year-over-year Free cash flow of $55.6 million, up 31% year-over-year

Exhibit 99.1 Doximity Announces Fiscal 2024 First Quarter Financial Results Total revenues of $108.5 million, up 20% year-over-year Operating cash flow of $57.2 million, up 28% year-over-year Free cash flow of $55.6 million, up 31% year-over-year SAN FRANCISCO, Calif., August 8, 2023 - Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced results

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 8, 2023 Doximity, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-40508 27-2485512 (State or Other Jurisdiction of Incorporation) (Commission File Numb

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001

Jennifer Chaloemtiarana Offer Letter

Exhibit 10.8 August 10, 2020 Jennifer Chaloemtiarana Dear Jennifer, It is with great pleasure that I offer you the position of General Counsel at Doximity (the “Company”). If you decide to join the Company starting August 24, 2020, you will receive an annualized base salary equal to $300,000 which will be paid semi-monthly in accordance with the Company's normal payroll procedures. You will also b

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): July 26, 2023 Doximity, Inc. (Exa

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): July 26, 2023 Doximity, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-40508 27-2485512 (State or Other Jurisdiction of Incorporation) (Commission File Numbe

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Definitive Proxy State

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 6, 2023 Doximity, Inc. (Exac

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 6, 2023 Doximity, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-40508 27-2485512 (State or Other Jurisdiction of Incorporation) (Commission File Number

INVESTOR DAY 2023 June 6, 2023 DOCS Investor Day — June 6, 2023 SAFE HARBOR This presentation and associated commentary may contain forward-looking statements, including statements regarding expectations of future results of operations or financial p

investorday2023slidedeck INVESTOR DAY 2023 June 6, 2023 DOCS Investor Day — June 6, 2023 SAFE HARBOR This presentation and associated commentary may contain forward-looking statements, including statements regarding expectations of future results of operations or financial performance of Doximity, market size and growth opportunities, the calculation of certain of our key financial and operating metrics, capital expenditures, plans for future operations, competitive position, technological capabilities, and strategic relationships, general business conditions and the assumptions underlying those statements.

Doximity Announces New Workflow Products, Long-Term Financial Targets at Inaugural Investor Day Company Charts Path to $1 Billion in Revenue by Fiscal Year 2028

Exhibit 99.1 Doximity Announces New Workflow Products, Long-Term Financial Targets at Inaugural Investor Day Company Charts Path to $1 Billion in Revenue by Fiscal Year 2028 SAN FRANCISCO, Calif., June 6, 2023 — Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced new physician workflow products and long-term financial targets during its inaugur

As filed with the U.S. Securities and Exchange Commission on May 26, 2023

As filed with the U.S. Securities and Exchange Commission on May 26, 2023 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Doximity, Inc. (Exact name of registrant as specified in its charter) Delaware 27-2485512 (State or other jurisdiction of incorporation or organization) (I.R.S. Employ

Subsidiaries of the Registrant.

Exhibit 21.1 SUBSIDIARIES OF DOXIMITY Name of Subsidiary Jurisdiction of Incorporation or Organization Curative Talent, LLC Delaware, U.S. Amion, LLC Delaware, U.S.

Form 10-K

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended March 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-40508

Filing Fee Table.

Exhibit 107 Calculation of Filing Fee Tables Form S-8 (Form Type) Doximity, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered(1) Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Equity Class A common stock, $0.001 par

Insider Trading Policy

Exhibit 19.1 DOXIMITY, INC. INSIDER TRADING POLICY This memorandum sets forth the policy of Doximity, Inc. and its subsidiaries (collectively, the “Company”) regarding trading in the Company’s securities as described below and the disclosure of information concerning the Company. This Insider Trading Policy (the “Insider Trading Policy”) is designed to prevent insider trading or the appearance of

Craig Overpeck Offer Letter

Exhibit 10.7 April 27, 2023 Craig Overpeck Dear Craig, We are excited to offer you a spot on our growing team at Doximity. Here are the details you likely care about most: Title SVP, Commercial Operations Start Date May 16, 2023 Annual Salary $300,000 Equity Grants $4M 4yr RSU, vests qtrly, no cliff $4M 4yr PSU, vests annually based on % to (stretch) goal Benefits Health insurance, 401k, Discretio

Doximity Announces Fourth Quarter and Fiscal Year 2023 Financial Results and New Senior Leadership Hires Q4 total revenues of $111.0 million, up 18% year-over-year Q4 net income margin of 28% and adjusted EBITDA margin of 44% Fiscal year 2023 total r

Exhibit 99.1 Doximity Announces Fourth Quarter and Fiscal Year 2023 Financial Results and New Senior Leadership Hires Q4 total revenues of $111.0 million, up 18% year-over-year Q4 net income margin of 28% and adjusted EBITDA margin of 44% Fiscal year 2023 total revenues of $419.1 million, up 22% year-over-year Fiscal year 2023 net income margin of 27% and adjusted EBITDA margin of 44% SAN FRANCISC

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 16, 2023 Doximity, Inc. (Exac

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 16, 2023 Doximity, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-40508 27-2485512 (State or Other Jurisdiction of Incorporation) (Commission File Number

DOCS / Doximity, Inc. / Whale Rock Capital Management LLC - WRDOCSGA2 Passive Investment

Schedule 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No.2)* Doximity, Inc. (Name of Issuer) Class A Common Stock, $0.001 par value per share (Title of Class of Securities) 26622P107 (CUSIP Number) Whale Rock Capital Management LLC 2 International Place, 24th Floor Boston, MA 02110 (617) 502-9909 (Name

DOCS / Doximity, Inc. / Tangney Jeffrey - SC 13G/A Passive Investment

SC 13G/A 1 doximity-schedule13gjeffta.htm SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES AND EXCHANGE ACT OF 1934 (Amendment No. 1)* Doximity, Inc. (Name of Issuer) Class A common stock (Title of Class of Securities) 26622P 107 (CUSIP Number) December 31, 2022 (Date of Event Which Requires Filing of this Statement) Check the appro

DOCS / Doximity, Inc. / AMERIPRISE FINANCIAL INC - SC 13G/A Passive Investment

SC 13G/A 1 d474850dsc13ga.htm SC 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Amendment #1 Under the Securities and Exchange Act of 1934 Doximity, Inc (Name of Issuer) Class A Common Stock (Title of Class of Securities) 26622P107 (CUSIP Number) December 31, 2022 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule p

DOCS / Doximity, Inc. / EMERGENCE CAPITAL PARTNERS II LP - SC 13G/A Passive Investment

SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 1)* Doximity, Inc. (Name of Issuer) CLASS A COMMON STOCK, $0.001 PAR VALUE PER SHARE (Title of Class of Securities) 26622P107 (CUSIP Number) December 31, 2022 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to desig

Joint Filing Statement

EX-99.A 2 d670693dex99a.htm EX-99.A EXHIBIT A Joint Filing Statement We, the undersigned, hereby express our agreement that the attached Schedule 13G is filed on behalf of each of us. Date: February 10, 2023 INTERWEST PARTNERS X, LP By: InterWest Management Partners X, LLC, its General Partner By: /s/ Gilbert H. Kliman by Karen A. Wilson, Power of Attorney Managing Director INTERWEST MANAGEMENT PA

DOCS / Doximity, Inc. / INTERWEST PARTNERS X LP - SC 13G/A Passive Investment

SC 13G/A 1 d670693dsc13ga.htm SC 13G/A OMB APPROVAL OMB Number: 3235-0145 Expires: February 28, 2010 Estimated average burden hours per response 10.4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (AMENDMENT NO 1)* Doximity, Inc. (Name of Issuer) Class A Common Stock (Title of Class of Securities) 26622P 10 7 (CUSIP Nu

DOCS / Doximity, Inc. / Clearbridge Investments, LLC Passive Investment

doxi22in1.htm - Generated by SEC Publisher for SEC Filing CUSIP NO. 26622P107 13G Page 1 of 7 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No.)* Doximity, Inc. (Name of Issuer) Class A common stock, $0.001 par value per share (Title of Class of Securities) 26622P107 (CUSIP Number) December 31, 2022 (Date o

Doximity Announces Fiscal 2023 Third Quarter Financial Results Total revenues of $115.3 million, up 18% year-over-year Operating cash flow of $48.7 million, up 78% year-over-year Free cash flow of $47.5 million, up 85% year-over-year

Exhibit 99.1 Doximity Announces Fiscal 2023 Third Quarter Financial Results Total revenues of $115.3 million, up 18% year-over-year Operating cash flow of $48.7 million, up 78% year-over-year Free cash flow of $47.5 million, up 85% year-over-year SAN FRANCISCO, Calif., February 9, 2023 - Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced resul

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number

DOCS / Doximity, Inc. / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment

SC 13G/A 1 tv0761-doximityincclassa.htm SCHEDULE 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 1)* Name of issuer: Doximity Inc. Class A Title of Class of Securities: Common Stock CUSIP Number: 26622P107 Date of Event Which Requires Filing of this Statement: December 30, 2022 Check the appropriate box to desig

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 9, 2023 Doximity, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-40508 27-2485512 (State or Other Jurisdiction of Incorporation) (Commission File Nu

DOCS / Doximity, Inc. / Threshold Ventures I, L.P. - SC 13G/A Passive Investment

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1 (b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO 13d-2 (b) (Amendment No. 1)* Doximity, Inc. (Name of Issuer) Class A Common Stock, $0.001 par value (Title of Class of Securities) 26622P107 (CUSIP Number) December 31, 2022 (Date of Event Which Requi

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file numbe

Doximity Announces Fiscal 2023 Second Quarter Financial Results Q2 total revenues of $102.2 million, up 29% year-over-year Q2 operating cash flow of $39.5 million, up 106% year-over-year Q2 free cash flow of $37.7 million, up 109% year-over-year

Exhibit 99.1 Doximity Announces Fiscal 2023 Second Quarter Financial Results Q2 total revenues of $102.2 million, up 29% year-over-year Q2 operating cash flow of $39.5 million, up 106% year-over-year Q2 free cash flow of $37.7 million, up 109% year-over-year SAN FRANCISCO, Calif., November 10, 2022 - Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today an

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 10, 2022 Doximity, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-40508 27-2485512 (State or Other Jurisdiction of Incorporation) (Commission File N

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001

Doximity Appoints Phoebe Yang to Its Board of Directors Experienced Director and Executive Brings Health System and Cloud Expertise

Exhibit 99.2 Doximity Appoints Phoebe Yang to Its Board of Directors Experienced Director and Executive Brings Health System and Cloud Expertise SAN FRANCISCO, August 4, 2022 ? Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced the appointment of Phoebe L. Yang to its Board of Directors. Ms. Yang has been General Manager at Amazon Web Services

Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 4, 2022 Doximity, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-40508 27-2485512 (State or Other Jurisdiction of Incorporation) (Commission File Numb

Doximity Announces Fiscal 2023 First Quarter Financial Results Q1 total revenues of $90.6 million, up 25% year-over-year Q1 operating cash flow of $44.8 million, up 35% year-over-year Q1 free cash flow of $42.6 million, up 32% year-over-year

Exhibit 99.1 Doximity Announces Fiscal 2023 First Quarter Financial Results Q1 total revenues of $90.6 million, up 25% year-over-year Q1 operating cash flow of $44.8 million, up 35% year-over-year Q1 free cash flow of $42.6 million, up 32% year-over-year SAN FRANCISCO, Calif., August 4, 2022 - Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced

Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): July 27, 2022 Doximity, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-40508 27-2485512 (State or Other Jurisdiction of Incorporation) (Commission File Numbe

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

DEF 14A 1 doximity-proxyfy22.htm DEF 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by R

Subsidiaries of the Registrant.

Exhibit 21.1 SUBSIDIARIES OF DOXIMITY Name of Subsidiary Jurisdiction of Incorporation or Organization Curative Talent, LLC Delaware, U.S. Amion, LLC Delaware, U.S.

As filed with the U.S. Securities and Exchange Commission on May 27, 2022

As filed with the U.S. Securities and Exchange Commission on May 27, 2022 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Doximity, Inc. (Exact name of registrant as specified in its charter) Delaware 27-2485512 (State or other jurisdiction of incorporation or organization) (I.R.S. Employ

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended March 31, 2022 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-40508 Doximity, Inc. Exa

2021 Stock Option and Incentive Plan, and forms of agreements thereunder.

Exhibit 4.2 DOXIMITY, INC. 2021 STOCK OPTION AND INCENTIVE PLAN SECTION 1. GENERAL PURPOSE OF THE PLAN; DEFINITIONS The name of the plan is the Doximity, Inc. 2021 Stock Option and Incentive Plan (the ?Plan?). The purpose of the Plan is to encourage and enable the officers, employees, Non- Employee Directors and Consultants of Doximity, Inc. (the ?Company?) and its Affiliates upon whose judgment,

Description of Securities.

Exhibit 4.3 DESCRIPTION OF SECURITIES The following is a summary of information concerning the capital stock of Doximity, Inc. (?us,? ?our,? ?we,? or the ?Company?) and certain provisions of our amended and restated certificate of incorporation (?Certificate?) and amended and restated bylaws (?Bylaws?). This summary does not purport to be complete and is qualified in its entirety by the provisions

Filing Fee Table.

Exhibit 107 Calculation of Filing Fee Tables Form S-8 (Form Type) Doximity, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered(1) Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Equity Class A common stock, $0.001 par

2021 Stock Option and Incentive Plan, and forms of agreements thereunder.

Exhibit 10.3 DOXIMITY, INC. 2021 STOCK OPTION AND INCENTIVE PLAN SECTION 1. GENERAL PURPOSE OF THE PLAN; DEFINITIONS The name of the plan is the Doximity, Inc. 2021 Stock Option and Incentive Plan (the ?Plan?). The purpose of the Plan is to encourage and enable the officers, employees, Non- Employee Directors and Consultants of Doximity, Inc. (the ?Company?) and its Affiliates upon whose judgment,

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): May 17, 2022 Doximity, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-40508 27-2485512 (State or Other Jurisdiction of Incorporation or Organization) (Commis

Doximity Announces Fourth Quarter and Fiscal Year 2022 Financial Results Q4 total revenues of $93.7 million, up 40% year-over-year Q4 net income margin of 39% and adjusted EBITDA margin of 42% Fiscal Year 2022 total revenues of $343.5 million, up 66%

Exhibit 99.1 Doximity Announces Fourth Quarter and Fiscal Year 2022 Financial Results Q4 total revenues of $93.7 million, up 40% year-over-year Q4 net income margin of 39% and adjusted EBITDA margin of 42% Fiscal Year 2022 total revenues of $343.5 million, up 66% year-over-year Fiscal year 2022 net income margin of 45% and adjusted EBITDA margin of 44% SAN FRANCISCO, Calif., May 17, 2022 - Doximit

DOCS / Doximity, Inc. / Tangney Jeffrey - SC 13G/A Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES AND EXCHANGE ACT OF 1934 (Amendment No. 1)* Doximity, Inc. (Name of Issuer) Class A common stock (Title of Class of Securities) 26622P 107 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which

DOCS / Doximity, Inc. / Doximity, Inc. - SC 13G Passive Investment

SC 13G 1 doximity-schedule13gjeffta.htm SC 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES AND EXCHANGE ACT OF 1934 (Amendment No. )* Doximity, Inc. (Name of Issuer) Class A common stock (Title of Class of Securities) 26622P 107 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriat

DOCS / Doximity, Inc. / AMERIPRISE FINANCIAL INC - SC 13G Passive Investment

SC 13G 1 d307543dsc13g.htm SC 13G SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities and Exchange Act of 1934 Doximity, Inc (Name of Issuer) Class A Common Stock (Title of Class of Securities) 26622P107 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which t

DOCS / Doximity, Inc. / INTERWEST PARTNERS X LP - SC 13G Passive Investment

SC 13G OMB APPROVAL OMB Number: 3235-0145 Expires: February 28, 2010 Estimated average burden hours per response 10.

Joint Filing Statement

EXHIBIT A Joint Filing Statement We, the undersigned, hereby express our agreement that the attached Schedule 13G is filed on behalf of each of us.

DOCS / Doximity, Inc. / Whale Rock Capital Management LLC - WRDOCS13GA1 Passive Investment

SC 13G/A 1 wrdocs13ga1.htm WRDOCS13GA1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No.1)* Doximity, Inc. (Name of Issuer) Class A Common Stock, $0.001 par value per share (Title of Class of Securities) 26622P107 (CUSIP Number) Whale Rock Capital Management LLC 2 International Place, 24th Floor Boston, MA

DOCS / Doximity, Inc. / EMERGENCE CAPITAL PARTNERS II LP - SC 13G Passive Investment

SC 13G 1 d319467dsc13g.htm SC 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. )* Doximity, Inc. (Name of Issuer) CLASS A COMMON STOCK, $0.001 PAR VALUE PER SHARE (Title of Class of Securities) 26622P107 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the

DOCS / Doximity, Inc. / VANGUARD GROUP INC - SCHEDULE 13G Passive Investment

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 Name of issuer: Doximity Inc. Class A Title of Class of Securities: Common Stock CUSIP Number: 26622P107 Date of Event Which Requires Filing of this Statement: December 31, 2021 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☒ Rule 13d-1(b) ☐ R

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number

DOCS / Doximity, Inc. / Threshold Ventures I, L.P. - SC 13G Passive Investment

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1 (b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO 13d-2 (b) (Amendment No. )* Doximity, Inc. (Name of Issuer) Class A Common Stock, $0.001 par value (Title of Class of Securities) 26622P107 (CUSIP Number) December 31, 2021 (Date of Event Which Requir

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): February 8, 2022 Doximity, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-40508 27-2485512 (State or Other Jurisdiction of Incorporation or Organization) (Co

Doximity Announces Fiscal 2022 Third Quarter Financial Results Total revenues of $97.9 million, up 67% year-over-year Net income margin of 57% and adjusted EBITDA margin of 48%

Exhibit 99.1 Doximity Announces Fiscal 2022 Third Quarter Financial Results Total revenues of $97.9 million, up 67% year-over-year Net income margin of 57% and adjusted EBITDA margin of 48% SAN FRANCISCO, Calif., February 8, 2022 - Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced results for the fiscal 2022 third quarter ended December 31, 2

DOCS / Doximity, Inc. / MORGAN STANLEY - MS INITIAL Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No.)* Doximity, Inc. - (Name of Issuer) Class A Common Stock - (Title of Class of Securities) 26622P107 - (CUSIP Number) December 31, 2021 - (Date Of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which

Second Amendment to Warrant to Purchase Shares of Class A Common Stock issued to U.S. News & World Report, L.P., dated October 8, 2021.

Exhibit 4.4 THIS WARRANT AND THE SECURITIES ISSUABLE UPON THE EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. THEY MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED, HYPOTHECATED, OR OTHERWISE TRANSFERRED EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR AN OPINION OF COUNSEL SATISFACTORY TO THE COMPANY THAT REGI

Amendment to Warrant to Purchase Shares of Class A Common Stock issued to U.S. News & World Report, L.P., dated September 2, 2021.

Exhibit 4.3 Amendment to Warrant This Amendment to that certain Warrant to Purchase Shares of Class A Common Stock issued by Doximity, Inc. (the "Company") to U.S. News & World Report, L.P. (the "Holder"), on June 14, 2021, (the ?Warrant?) is effective as of September 2, 2021 (?Effective Date?). Capitalized terms used herein that are not otherwise defined shall have the meanings assigned to them i

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file numbe

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): November 9, 2021 Doximity, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-40508 27-2485512 (State or Other Jurisdiction of Incorporation or Organization) (Co

Doximity Announces Fiscal 2022 Second Quarter Financial Results Total revenues of $79.4 million, up 76% year-over-year Net income margin of 45% and adjusted EBITDA margin of 41%

Exhibit 99.1 Doximity Announces Fiscal 2022 Second Quarter Financial Results Total revenues of $79.4 million, up 76% year-over-year Net income margin of 45% and adjusted EBITDA margin of 41% SAN FRANCISCO, Calif., November 9, 2021 - Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced results for the fiscal 2022 second quarter ended September 30

As filed with the U.S. Securities and Exchange Commission on August 12, 2021

As filed with the U.S. Securities and Exchange Commission on August 12, 2021 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Doximity, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 27-2485512 (I.R.S. Emp

Warrant to Purchase Shares of Class A Common Stock issued to U.S. News & World Report, L.P., dated June 14, 2021.

THIS WARRANT AND THE SECURITIES ISSUABLE UPON THE EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001

Doximity Announces Fiscal 2022 First Quarter Financial Results Total revenues of $72.7 million, up 100% year-over-year Net income margin of 36% and adjusted EBITDA margin of 43%

Exhibit 99.1 Doximity Announces Fiscal 2022 First Quarter Financial Results Total revenues of $72.7 million, up 100% year-over-year Net income margin of 36% and adjusted EBITDA margin of 43% SAN FRANCISCO, Calif., August 10, 2021 - Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced results for the fiscal 2022 first quarter ended June 30, 2021.

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): August 10, 2021 Doximity, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-40508 27-2485512 (State or Other Jurisdiction of Incorporation or Organization) (Com

JOINT FILING AGREEMENT

Exhibit 99.1 JOINT FILING AGREEMENT This Joint Filing Agreement, dated as of July 2, 2021 is by and among Whale Rock Capital Management LLC and Alexander Sacerdote (collectively, the "Filers"). Each of the Filers may be required to file with the United States Securities and Exchange Commission a statement on Schedule 13G and/or 13D with respect to Class A Common Stock, $0.001 par value per share,

DOCS / Doximity, Inc. / Whale Rock Capital Management LLC - WRDOCS13G Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No.)* Doximity, Inc. (Name of Issuer) Class A Common Stock, $0.001 par value per share (Title of Class of Securities) 26622P107 (CUSIP Number) Whale Rock Capital Management LLC 2 International Place, 24th Floor Boston, MA 02110 (617) 502-9909 (Name, Address and

23,300,000 Shares CLASS A COMMON STOCK

Filed Pursuant to Rule 424(b)(4) Registration No: 333-256584 23,300,000 Shares CLASS A COMMON STOCK Doximity, Inc.

As filed with the U.S. Securities and Exchange Commission on June 24, 2021

As filed with the U.S. Securities and Exchange Commission on June 24, 2021 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Doximity, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 27-2485512 (State or Other Jurisdiction of Incorporation or Organization) (I.R.S. Emplo

As filed with the U.S. Securities and Exchange Commission on June 24, 2021

As filed with the U.S. Securities and Exchange Commission on June 24, 2021 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Doximity, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 27-2485512 (State or Other Jurisdiction of Incorporation or Organization) (I.R.S. Emplo

Doximity, Inc. 500 3rd St. Suite 510 San Francisco, California 94107

Doximity, Inc. 500 3rd St. Suite 510 San Francisco, California 94107 VIA EDGAR June 23, 2021 U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, NE Washington, DC 20549 Attention: Matthew Derby Larry Spirgel Joseph Cascarano Robert Littlepage Re: Doximity, Inc. Acceleration Request for Registration Statement on Form S-1 File No. 333-256584 Dear Ladies and Gentleme

[Signature page follows]

CORRESP 1 filename1.htm June 23, 2021 United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, DC 20549 Attention: Matthew Derby Larry Spirgel Joseph Cascarano Robert Littlepage Re: Doximity, Inc. Registration Statement on Form S-1 (File No. 333-256584) Ladies and Gentlemen: Pursuant to Rule 460 of the General Rules and Regulations under the S

As filed with the Securities and Exchange Commission on June 22, 2021

S-1/A 1 doximity-sx1a2freecashflow.htm S-1/A As filed with the Securities and Exchange Commission on June 22, 2021 Registration No. 333-256584 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Amendment No. 2 to FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Doximity, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 7371 27-2485512 (State

2021 Employee Stock Purchase Plan.

Exhibit 10.4 DOXIMITY, INC. 2021 EMPLOYEE STOCK PURCHASE PLAN The purpose of the Doximity, Inc. 2021 Employee Stock Purchase Plan (the ?Plan?) is to provide eligible employees of Doximity, Inc. (the ?Company?) and each Designated Subsidiary (as defined in Section 11) with opportunities to purchase shares of the Company?s Class A common stock, par value $0.001 per share (the ?Common Stock?). 4,500,

Form of Underwriting Agreement.

Exhibit 1.1 [?] Shares DOXIMITY, INC. CLASS A COMMON STOCK, PAR VALUE $0.001 PER SHARE UNDERWRITING AGREEMENT [?], 2021 [?], 2021 Morgan Stanley & Co. LLC Goldman Sachs & Co. LLC J.P. Morgan Securities LLC c/o Morgan Stanley & Co. LLC 1585 Broadway New York, New York 10036 c/o Goldman Sachs & Co. LLC 200 West Street New York, New York 10282 c/o J.P. Morgan Securities LLC 383 Madison Avenue New Yor

Amended and Restated Certificate of Incorporation of the Registrant.

Exhibit 3.2 DOXIMITY, INC. AMENDED AND RESTATED CERTIFICATE OF INCORPORATION Doximity, Inc. (the ?Corporation?), a corporation organized and existing under the laws of the State of Delaware, hereby certifies as follows: A. The Corporation was originally incorporated pursuant to the General Corporation Law of the State of Delaware (the ?DGCL?) on April 16, 2010 under the name 3MD Communications, In

Form of Indemnification Agreement between the Registrant and each of its directors and executive officers.

Exhibit 10.1 DOXIMITY, INC. INDEMNIFICATION AGREEMENT This Indemnification Agreement (?Agreement?) is made as of by and between Doximity, Inc., a Delaware corporation (the ?Company?), and (?Indemnitee?). RECITALS WHEREAS, the Company desires to attract and retain the services of highly qualified individuals, such as Indemnitee, to serve the Company; WHEREAS, in order to induce Indemnitee to provid

Form of Warrant to Purchase Shares of Class A Common Stock issued to U.S. News & World Report, L.P

Exhibit 4.4 THIS WARRANT AND THE SECURITIES ISSUABLE UPON THE EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. THEY MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED, HYPOTHECATED, OR OTHERWISE TRANSFERRED EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR AN OPINION OF COUNSEL SATISFACTORY TO THE COMPANY THAT REGI

Form 8-A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 DOXIMITY, INC. (Exact name of registrant as specified in its charter) Delaware (State of incorporation or organization) 27-2485512 (I.R.S. Employer Identification No.) 500 3rd St., Suite 510 San Fr

Non-Employee Director Compensation Policy.

Exhibit 10.6 DOXIMITY, INC. NON-EMPLOYEE DIRECTOR COMPENSATION POLICY The purpose of this Non-Employee Director Compensation Policy (the ?Policy?) of Doximity, Inc., a Delaware corporation (the ?Company?), is to provide a total compensation package that enables the Company to attract and retain, on a long-term basis, high-caliber directors who are not employees or officers of the Company or its su

2010 Equity Incentive Plan, as amended, and forms of agreements thereunder.

Exhibit 10.2 DOXIMITY, INC. 2010 EQUITY INCENTIVE PLAN As Adopted on April 16, 2010 Amended March 10, 2011, August 27, 2012, February 23, 2014, April 4, 2014, March 21, 2016, June 6, 2018, June 10, 2020, February 16, 2021, and May 19, 2021 1. Purposes of the Plan. The purposes of this Plan are: to attract and retain the best available personnel for positions of substantial responsibility, to provi

Senior Executive Cash Incentive Bonus Plan.

Exhibit 10.5 DOXIMITY, INC. SENIOR EXECUTIVE CASH INCENTIVE BONUS PLAN 1.Purpose This Senior Executive Cash Incentive Bonus Plan (the ?Incentive Plan?) is intended to provide an incentive for superior work and to motivate eligible executives of Doximity, Inc. (the ?Company?) and its subsidiaries toward even higher achievement and business results, to tie their goals and interests to those of the C

2021 Stock Option and Incentive Plan, and forms of agreements thereunder.

Exhibit 10.3 DOXIMITY, INC. 2021 STOCK OPTION AND INCENTIVE PLAN SECTION 1.GENERAL PURPOSE OF THE PLAN; DEFINITIONS The name of the plan is the Doximity, Inc. 2021 Stock Option and Incentive Plan (the ?Plan?). The purpose of the Plan is to encourage and enable the officers, employees, Non-Employee Directors and Consultants of Doximity, Inc. (the ?Company?) and its Affiliates upon whose judgment, i

As filed with the Securities and Exchange Commission on June 15, 2021

As filed with the Securities and Exchange Commission on June 15, 2021 Registration No.

Amended and Restated Certificate of Incorporation of the Registrant, as currently in effect.

Exhibit 3.1 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF DOXIMITY, INC. Doximity, Inc., a corporation organized and existing under the laws of the State of Delaware (the ?Corporation?), certifies that: 1.The name of the Corporation is Doximity, Inc. The Corporation?s original Certificate of Incorporation was filed with the Secretary of State of the State of Delaware on April 16, 2010 under

Form of Amended and Restated Bylaws of the Registrant to be in effect immediately prior to the completion of this offering.

Exhibit 3.4 AMENDED AND RESTATED BYLAWS OF DOXIMITY, INC. (effective upon the effectiveness of the corporation?s registration statement on Form S-1) TABLE OF CONTENTS Page Article I CORPORATE OFFICES 1 1.1 Registered Office 1 1.2 Other Offices 1 Article II MEETINGS OF STOCKHOLDERS 1 2.1 Place of Meetings 1 2.2 Annual Meeting 1 2.3 Special Meeting 1 2.4 Advance Notice Procedures 2 2.5 Notice of Sto

CONFIDENTIAL TREATMENT REQUESTED BY DOXIMITY, INC.

CORRESP 1 filename1.htm Goodwin Procter llp 601 Marshall Street Redwood City, CA 94063 goodwinlaw.com +1 650 752 3100 CONFIDENTIAL TREATMENT REQUESTED BY DOXIMITY, INC. CERTAIN PORTIONS OF THIS LETTER AS FILED VIA EDGAR HAVE BEEN OMITTED AND FILED SEPARATELY WITH THE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED PURSUANT TO 17 CFR 200.83 WITH RESPECT TO THE OMITTED PORTIONS. OMITTED INFORM

Subsidiaries of the Registrant.

Exhibit 21.1 SUBSIDIARIES OF DOXIMITY, INC. Name of Subsidiary Jurisdiction of Incorporation or Organization Curative Talent, LLC Delaware, U.S.

As filed with the Securities and Exchange Commission on May 28, 2021

As filed with the Securities and Exchange Commission on May 28, 2021 Registration No.

Bylaws of the Registrant, as amended, as currently in effect.

Exhibit 3.3 BYLAWS OF 3MD COMMUNICATIONS, INC. Adopted April 16, 2010 TABLE OF CONTENTS Page Article I — MEETINGS OF STOCKHOLDERS 1 1.1 Place of Meetings 1 1.2 Annual Meeting 1 1.3 Special Meeting 1 1.4 Notice of Stockholders’ Meetings 2 1.5 Quorum 2 1.6 Adjourned Meeting; Notice 2 1.7 Conduct of Business 2 1.8 Voting 3 1.9 Stockholder Action by Written Consent Without a Meeting 3 1.10 Record Date

Third Certificate of Amendment to Amended and Restated Certificate of Incorporation of the Registrant

Exhibit 3.1.3 CERTIFICATE OF AMENDMENT TO THE AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF DOXIMITY, INC. Doximity, Inc., a corporation organized and existing under the laws of the State of Delaware (the ?Corporation?), does hereby certify: 1.The name of the Corporation is Doximity, Inc. 2.The Corporation?s original Certificate of Incorporation was filed with the Secretary of State of the

Fourth Certificate of Amendment to Amended and Restated Certificate of Incorporation of the Registrant

EX-3.1.4 7 exhibit314-sx1.htm EX-3.1.4 Exhibit 3.1.4 CERTIFICATE OF AMENDMENT TO THE AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF DOXIMITY, INC. Doximity, Inc., a corporation organized and existing under the laws of the State of Delaware (the “Corporation”), does hereby certify: 1.The name of the Corporation is Doximity, Inc. 2.The Corporation’s original Certificate of Incorporation was fi

Certificate of Amendment to Amended and Restated Certificate of Incorporation of the Registrant

EX-3.1.5 8 exhibit315-sx1.htm EX-3.1.5 Exhibit 3.1.5 CERTIFICATE OF AMENDMENT TO THE AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF DOXIMITY, INC. Doximity, Inc., a corporation organized and existing under the laws of the State of Delaware (the “Corporation”), does hereby certify: 1.The name of the Corporation is Doximity, Inc. 2.The Corporation’s original Certificate of Incorporation was fi

Second Certificate of Amendment to Amended and Restated Certificate of Incorporation of the Registrant

Exhibit 3.1.2 CERTIFICATE OF AMENDMENT TO THE AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF DOXIMITY, INC. Doximity, Inc., a corporation organized and existing under the laws of the State of Delaware (the “Corporation”), does hereby certify: 1.The name of the Corporation is Doximity, Inc. 2.The Corporation’s original Certificate of Incorporation was filed with the Secretary of State of the

Amended and Restated Certificate of Incorporation of the Registrant, as currently in effect.

EX-3.1 2 exhibit31-sx1.htm EX-3.1 Exhibit 3.1 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF DOXIMITY, INC. Doximity, Inc., a corporation organized and existing under the laws of the State of Delaware (the “Corporation”), certifies that: 1. The name of the Corporation is Doximity, Inc. The Corporation’s original Certificate of Incorporation was filed with the Secretary of State of the State

Amended and Restated Investors’ Rights Agreement, dated April 10, 2014, by and among the Registrant and certain of its stockholders.

Exhibit 4.2 DOXIMITY, INC. AMENDED AND RESTATED INVESTORS? RIGHTS AGREEMENT APRIL 10, 2014 TABLE OF CONTENTS Page SECTION 1 Definitions 1 1.1 Certain Definitions 1 SECTION 2 Registration Rights 4 2.1 Requested Registration 4 2.2 Company Registration 6 2.3 Registration on Form S-3 7 2.4 Expenses of Registration 8 2.5 Registration Procedures 8 2.6 Indemnification 9 2.7 Information by Holder 11 2.8 R

Warrant to Purchase Shares of Common Stock issued to U.S. News & World Report, L.P., dated March 10, 2017.

EX-4.3 11 exhibit43-sx1.htm EX-4.3 Exhibit 4.3 THIS WARRANT AND THE SECURITIES ISSUABLE UPON THE EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. THEY MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED, HYPOTHECATED, OR OTHERWISE TRANSFERRED EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR AN OPINION OF COUNSEL SA

Form of Class A common stock certificate of the Registrant.

EX-4.1 9 exhibit41s-1.htm EX-4.1 Exhibit 4.1 D E L AW A R E SEAL DO XIMITY, INC. CO RPORATE April 16, 2010 DOCS FULLY PAID AND NONASSESSABLE SHARES OF CLASS A COMMON STOCK, $0.001 PAR VALUE PER SHARE, OF Doximity, Inc. transferable on the books of the Corporation in person or by duly authorized attorney upon surrender of this Certificate properly endorsed. This Certificate is not valid until count

Certificate of Amendment to Amended and Restated Certificate of Incorporation of the Registrant

Exhibit 3.1.1 CERTIFICATE OF AMENDMENT TO THE AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF DOXIMITY, INC. Doximity, Inc., a corporation organized and existing under the laws of the State of Delaware (the “Corporation”), does hereby certify: 1.The name of the Corporation is Doximity, Inc. 2.The Corporation’s original Certificate of Incorporation was filed with the Secretary of State of the

CERTIFICATE OF AMENDMENT TO THE AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF DOXIMITY, INC.

EX-3.1(3) 4 filename4.htm Exhibit 3.1.3 CERTIFICATE OF AMENDMENT TO THE AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF DOXIMITY, INC. Doximity, Inc., a corporation organized and existing under the laws of the State of Delaware (the “Corporation”), does hereby certify: 1.The name of the Corporation is Doximity, Inc. 2.The Corporation’s original Certificate of Incorporation was filed with the

AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF DOXIMITY, INC.

Exhibit 3.1 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF DOXIMITY, INC. Doximity, Inc., a corporation organized and existing under the laws of the State of Delaware (the ?Corporation?), certifies that: 1. The name of the Corporation is Doximity, Inc. The Corporation?s original Certificate of Incorporation was filed with the Secretary of State of the State of Delaware on April 16, 2010 unde

[Signature Page Follows]

Goodwin Procter LLP 601 Marshall St, Redwood City, CA 94063 goodwinlaw.com +1 650 752 3100 May 7, 2021 VIA EDGAR United States Securities and Exchange Commission Division of Corporate Finance 100 F Street, NE Washington, D.C. 20549 Attention: Matthew Derby Larry Spirgel Joseph Cascarano Robert Littlepage Re: Doximity, Inc. Confidential Amendment No. 1 to Draft Registration Statement on Form S-1 Su

CERTIFICATE OF AMENDMENT TO THE AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF DOXIMITY, INC.

Exhibit 3.1.2 CERTIFICATE OF AMENDMENT TO THE AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF DOXIMITY, INC. Doximity, Inc., a corporation organized and existing under the laws of the State of Delaware (the ?Corporation?), does hereby certify: 1.The name of the Corporation is Doximity, Inc. 2.The Corporation?s original Certificate of Incorporation was filed with the Secretary of State of the

CERTIFICATE OF AMENDMENT TO THE AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF DOXIMITY, INC.

EX-3.1(1) 2 filename2.htm Exhibit 3.1.1 CERTIFICATE OF AMENDMENT TO THE AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF DOXIMITY, INC. Doximity, Inc., a corporation organized and existing under the laws of the State of Delaware (the “Corporation”), does hereby certify: 1.The name of the Corporation is Doximity, Inc. 2.The Corporation’s original Certificate of Incorporation was filed with the

As confidentially submitted to the Securities and Exchange Commission on May 7, 2021. This Amendment No. 2 to the draft registration statement has not been filed publicly with the Securities and Exchange Commission, and all information herein remains

DRS/A 1 filename1.htm As confidentially submitted to the Securities and Exchange Commission on May 7, 2021. This Amendment No. 2 to the draft registration statement has not been filed publicly with the Securities and Exchange Commission, and all information herein remains strictly confidential. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-1 R

BYLAWS OF 3MD COMMUNICATIONS, INC. Adopted April 16, 2010

Exhibit 3.3 BYLAWS OF 3MD COMMUNICATIONS, INC. Adopted April 16, 2010 TABLE OF CONTENTS Page Article I ? MEETINGS OF STOCKHOLDERS 1 1.1 Place of Meetings 1 1.2 Annual Meeting 1 1.3 Special Meeting 1 1.4 Notice of Stockholders? Meetings 2 1.5 Quorum 2 1.6 Adjourned Meeting; Notice 2 1.7 Conduct of Business 2 1.8 Voting 3 1.9 Stockholder Action by Written Consent Without a Meeting 3 1.10 Record Date

DOXIMITY, INC. AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT APRIL 10, 2014 TABLE OF CONTENTS Page SECTION 1 Definitions 1 1.1 Certain Definitions 1 SECTION 2 Registration Rights 4 2.1 Requested Registration 4 2.2 Company Registration 6 2.3 Regist

EX-4.2 8 filename8.htm Exhibit 4.2 DOXIMITY, INC. AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT APRIL 10, 2014 TABLE OF CONTENTS Page SECTION 1 Definitions 1 1.1 Certain Definitions 1 SECTION 2 Registration Rights 4 2.1 Requested Registration 4 2.2 Company Registration 6 2.3 Registration on Form S-3 7 2.4 Expenses of Registration 8 2.5 Registration Procedures 8 2.6 Indemnification 9 2.7 Informa

DOXIMITY, INC. WARRANT TO PURCHASE SHARES OF COMMON STOCK

Exhibit 4.3 THIS WARRANT AND THE SECURITIES ISSUABLE UPON THE EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. THEY MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED, HYPOTHECATED, OR OTHERWISE TRANSFERRED EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR AN OPINION OF COUNSEL SATISFACTORY TO THE COMPANY THAT REGI

CERTIFICATE OF AMENDMENT TO THE AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF DOXIMITY, INC.

EX-3.1(4) 5 filename5.htm Exhibit 3.1.4 CERTIFICATE OF AMENDMENT TO THE AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF DOXIMITY, INC. Doximity, Inc., a corporation organized and existing under the laws of the State of Delaware (the “Corporation”), does hereby certify: 1.The name of the Corporation is Doximity, Inc. 2.The Corporation’s original Certificate of Incorporation was filed with the

[Signature Page Follows]

DRSLTR 1 filename1.htm Goodwin Procter LLP 601 Marshall St, Redwood City, CA 94063 goodwinlaw.com +1 650 752 3100 April 16, 2021 VIA EDGAR United States Securities and Exchange Commission Division of Corporate Finance 100 F Street, NE Washington, D.C. 20549 Attention: Matthew Derby Larry Spirgel Joseph Cascarano Robert Littlepage Re: Doximity, Inc. Confidential Draft Registration Statement on Form

As confidentially submitted to the Securities and Exchange Commission on April 16, 2021. This Amendment No. 1 to the draft registration statement has not been filed publicly with the Securities and Exchange Commission, and all information herein rema

As confidentially submitted to the Securities and Exchange Commission on April 16, 2021.

As confidentially submitted to the Securities and Exchange Commission on March 5, 2021. This draft registration statement has not been filed publicly with the Securities and Exchange Commission, and all information herein remains strictly confidentia

DRS 1 filename1.htm As confidentially submitted to the Securities and Exchange Commission on March 5, 2021. This draft registration statement has not been filed publicly with the Securities and Exchange Commission, and all information herein remains strictly confidential. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-1 REGISTRATION STATEMENT U